OpenVSafe by OpenVAERS
Search V-safe

AXU-80804-84896

1 vaccination 1 coded response 3 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
442 / OH
Registered
2021-03-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-09
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-03-10
    Registered in v-safe
  3. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-10
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Fair · Fatigue or tiredness
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-17

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Janssen/Johnson & Johnson

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-12

Systemic reaction (other): Sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROOropharyngeal pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release